Skip to content
10-Q

Quarterly Report

EMMAUS LIFE SCIENCES, INC. EMMA

0001193125-26-226362

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 70.19M sh
Shares Diluted Q1 2026 · Mar 31, 2026 70.19M sh
Shares Diluted Q1 2026 · Mar 31, 2025 63.87M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$344K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $279K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.07M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.13M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$67.86M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$63.61M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$58.6M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$56.48M
Current Liabilities Q1 2026 · Mar 31, 2026 $70.54M
Current Liabilities Q1 2026 · Dec 31, 2025 $69.07M
Total Liabilities Q1 2026 · Mar 31, 2026 $86.56M
Total Liabilities Q1 2026 · Dec 31, 2025 $85.04M
Current Assets Q1 2026 · Mar 31, 2026 $6M
Current Assets Q1 2026 · Dec 31, 2025 $7.75M
Total Assets Q1 2026 · Mar 31, 2026 $18.7M
Total Assets Q1 2026 · Dec 31, 2025 $21.44M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.04
Eps Basic Q1 2026 · Mar 31, 2026 −$0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.04
Sga Expense Q1 2026 · Mar 31, 2026 $1.85M
Sga Expense Q1 2026 · Mar 31, 2025 $2.34M
Rd Expense Q1 2026 · Mar 31, 2026 $40K
Rd Expense Q1 2026 · Mar 31, 2025 $176K
Net Income Q1 2026 · Mar 31, 2026 −$3.34M
Net Income Q1 2026 · Mar 31, 2025 −$2.33M
Operating Income Q1 2026 · Mar 31, 2026 −$823K
Operating Income Q1 2026 · Mar 31, 2025 −$980K
Gross Profit Q1 2026 · Mar 31, 2026 $1.81M
Gross Profit Q1 2026 · Mar 31, 2025 $2.18M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $168K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $225K
Revenue Q1 2026 · Mar 31, 2026 $1.98M
Revenue Q1 2026 · Mar 31, 2025 $2.41M